Nevada Revised Statutes 453C.120 – Pharmacist authorized to furnish opioid antagonist with or without prescription; adoption of standardized procedures or protocols; training of pharmacists
1. Notwithstanding any other provision of law, a registered pharmacist may, with or without a prescription from a health care professional authorized to prescribe an opioid antagonist, furnish an opioid antagonist in accordance with standardized procedures or protocols developed and approved by the State Board of Pharmacy pursuant to this section.
Terms Used In Nevada Revised Statutes 453C.120
- controlled substance: means a drug, immediate precursor or other substance which is listed in schedule I, II, III, IV or V for control by the State Board of Pharmacy pursuant to Nevada Revised Statutes 0.031
- person: means a natural person, any form of business or social organization and any other nongovernmental legal entity including, but not limited to, a corporation, partnership, association, trust or unincorporated organization. See Nevada Revised Statutes 0.039
2. The State Board of Pharmacy:
(a) May, in consultation with representatives of the Nevada Pharmacist Association, other appropriate professional licensing boards, state agencies and other interested parties, develop standardized procedures or protocols to enable a registered pharmacist and other appropriate entities to furnish an opioid antagonist pursuant to this section.
(b) May not prohibit a pharmacist from furnishing an opioid antagonist to a person without a prescription.
3. Standardized procedures or protocols adopted pursuant to this section must ensure that a person receive education before being furnished with an opioid antagonist pursuant to this section. The education must include, without limitation:
(a) Information concerning the prevention and recognition of and responses to opioid-related drug overdoses;
(b) Methods for the safe administration of opioid antagonists to a person experiencing an opioid-related drug overdose;
(c) Potential side effects and adverse events connected with the administration of opioid antagonists;
(d) The importance of seeking emergency medical assistance for a person experiencing an opioid-related drug overdose even after the administration of an opioid antagonist; and
(e) Information concerning the provisions of NRS 453C.150.
4. A pharmacist shall, before furnishing an opioid antagonist pursuant to this section, complete a training program on the use of opioid antagonists. The program must include at least 1 hour of approved continuing education on the use of opioid antagonists.
5. This section does not:
(a) Affect any provision of law concerning the confidentiality of medical information.
(b) Confer any authority on a registered pharmacist to prescribe an opioid antagonist or any other prescription medication or controlled substance.